Toll-like receptor 5 ligands and methods of use

Details Toll-like receptor 5 ligands and methods of use Toll-like receptor 5 ligands and methods of use

2011-03-29

2011-03-29

Zeman, Robert A (Department: 1645)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C424S234100, C435S007200, C435S183000, C514S054000

Reexamination Certificate

active

07915381

ABSTRACT:
The invention provides an immunomodulatory flagellin peptide having at least about 10 amino acids of substantially the amino acid sequence GAVQNRFNSAIT (SEQ ID NO:2), or a modification thereof, and having toll-like receptor 5 (TLR5) binding. Methods of inducing an immune response are also provided.

REFERENCES:
patent: 5194254 (1993-03-01), Barber et al.
patent: 5420109 (1995-05-01), Suto
patent: 5612035 (1997-03-01), Howell
patent: 5614192 (1997-03-01), Vandenbark
patent: 5618533 (1997-04-01), Flavell et al.
patent: 5677427 (1997-10-01), Goldenberg et al.
patent: 5817308 (1998-10-01), Scott et al.
patent: 5837825 (1998-11-01), Meinersmann et al.
patent: 6030624 (2000-02-01), Russell et al.
patent: 6130082 (2000-10-01), Majarian et al.
patent: 6548295 (2003-04-01), Andre et al.
patent: 6610298 (2003-08-01), Hasan et al.
patent: 6610661 (2003-08-01), Carson et al.
patent: 6685935 (2004-02-01), Pawelek et al.
patent: 6703487 (2004-03-01), Bird et al.
patent: 6740487 (2004-05-01), Schwartz et al.
patent: 6753166 (2004-06-01), Sims et al.
patent: 6797813 (2004-09-01), de Waal Malefyt et al.
patent: 2003/0232055 (2003-12-01), Medzhitov
patent: WO-02/09748 (2002-02-01), None
patent: WO-02/085933 (2002-10-01), None
Cookson, BT et al, The American Association of Immunologists, vol. 158, pp. 4310-4319, 1997.
Joys, Terence M, Journal of Biological Chemistry, vol. 260(29), Dec. 15, 1985, pp. 15758-15761.
Namba, K et al, Nature, vol. 342, Dec. 7, 1989, pp. 648-654.
Sebastiani, G et al, Genomics, vol. 64, pp. 230-240, Mar. 15, 2000.
Sztein, MB et al, Journal of Infectious Diseases, Dec. 1994, vol. 170(6), pp. 1508-1517.
van Asten, Ajam et al, Journal of Bacteriology, vol. 177(6), pp. 1610-1613, Mar. 1995.
Xu, D et al, The American Association of Immunologists, vol. 160, pates 1285-1289, 1998.
Kopp, EB et al, The Toll-receptor Family and control of innate immunity, Current Opinion in Immunology, 1999, vol. 11, pp. 13-18.
Cario, E et al, Differential Alteration in INtestinal Epithelial Cell Expression of Toll like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowl Disease, Infection and Immunity, vol. 68(12), pp. 7010-7017, Dec. 2000.
Rock, Fernando L et al, PNAS(USA), vol. 95, pp. 588-593, Jan. 1998, A family of human receptors structurally related toDrosophilaToll.
Bowie et al (Science, 1990, 257:1306-1310).
Aderem and Ulevitch, “Toll-like receptors in the induction of the innate immune response,”Nature406:782-7 (2000).
Brightbill and Modlin, “Toll-like receptors: molecular mechanisms of the mammalian immune response,”Immunology101:1-10 (2000).
Brightbill et al., “Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-like Receptors,”Science285:732-736 (1999).
Cario and Podolsky, “Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease,”Infect. Immun. 68:7010-7017 (2000).
Ciacci-Woolwine et al., “Induction of cytokine synthesis by flagella from gram-negative bacteria may be dependent on the activation or differentiation state of human monocytes,”Infect. Immun. 67:5176-85 (1999).
Ciacci-Woolwine et al., “SalmonellaFlagellin Induces Tumor Necrosis Factor Alpha in a Human Promonocytic Cell Line,”Infect. Immun. 66:1127-1134 (1998).
Chaudhary et al., “Cloning and Characterization of Two Toll/Interleukin-1 Receptor-like Genes TIL3 and TIL4: Evidence for a Multi-gene Receptor Family in Humans,”Blood91:4020-4027 (1998).
das Gracas Luna et al., “Salmonellaflagellin fused with a linear epitope of colonization factor antigen I (CFA/I) can prime antibody responses against homologous and heterologous fimbriae of enterotoxigenicEscherichia coli,” Res. Microbial. 151:575-82 (2000).
Eaves-Pyles et al., “Flagellin, a novel mediator of salmonella-induced epithelial activation and systemic inflammation: IkBα degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction”The Journal of Immunology166:1248-1260 (2001).
Gewirtz et al., “Salmonella typhimuriumtranslocates flagellin across intestinal epithelia, inducing a proinflammatory response,”The Journal of Clinical Investigation107:99-109 (2001).
Fujita and Yamaguchi, “Studies on H-O variants inSalmonellain relation to phase variation,”J. Gen. Microbial. 76:127-34 (1973).
Gomez-Gomez and Boller, “FLS2: an LRR receptor-like kinase involved in the perception of the bacterial elicitor flagellin in Arabidopsis,”Mol. Cell5:1003-11 (2000).
Ibrahim et al., “Method for the isolation of highly purifiedSalmonellaflagellins,”J. Clin. Microbial. 22:1040-1044 (1985).
Joys and Street, “Mapping of T-Cell Epitopes of Flagellar AntigendofSalmonella muenchen,” Infect. Immun. 61:1146-1148 (1993).
Joys and Schodel, “Epitope Mapping of thedFlagellar Antigen ofSalmonella muenchen,” Infect. Immun. 59:3330-3332 (1991).
Kuwajima, “Construction of a Minimum-Size Functional Flagellin ofEscherichia coli,” Bacteriol. 170:3305-3309 (1988).
Kuwajima et al., “Export of an N-terminal Frament ofEscherichia coliFlagellin by a Flagellum-specific pathway,”Proc. Natl. Acade. Sci. USA86:4953-4957 (1989).
Logan et al., “Evidence for Posttranslational Modification and Gene Duplication ofCampylobacterFlagellin,”J. Bacteriology171:3031-3038.
McDermott et al., “High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation,”Infect. Immun. 68:5525-9 (2000).
McEwen et al., “Synthetic recombinant vaccine expressing influenza haemagglutinin epitope inSalmonellaflagellin leads to partial protection in mice,”Vaccine10:405-11 (1992).
McSorley et al., “Characterization of CD4+ T Cell Responses During Natural Infection withSalmonella typhimurium1,” J. Immunol. 164:986-993 (2000).
Means et al., “The biology of Toll-like receptors,”Cytokine Growth Factor Rev. 11:219-32 (2000).
Medzhitov et al., “A human homologue of theDrosophilaToll protein signals activation of adaptive immunity,”Nature388:394-97 (1997).
Medzhitov et al., “MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways,”Mol. Cell2:253-68 (1998).
Mimori-Kiyosue et al., “Locations of terminal segments of flagellin in the filament structure and their roles in polymerization and polymorphism,”J. Mol. Biol. 270:222-37 (1997).
Muzio et al., “Differential Expression and Regulation of Toll-like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells,”J. Immunol. 164:5998-6004 (2000).
Newton et al., “Aromatic-dependentSalmonellawith Foreign Epitope Insert in Flagellin as Live Vaccine,”Vaccines90:439-445 (1990).
Newton et al., “Immune Response to Cholera Toxin Epitope Inserted inSalmonellaFlagellin,”Science244:70-72 (1989).
Ozinsky et al., “The Repertoire for Pattern Recognition of Pathogens by the Innate Immune System Is Defined by Cooperation Between Toll-like Receptors,”Proc. Natl. Acad. Sci. 97:13766-13771 (2000).
Peel et al., “Temperature-dependent Expression of Flagella ofListeria MonocytogenesStudied by Electron Microscopy, SDS-PAGE and Western Blotting,”J. Gen. Microbial. 134:2171-2178 (1988).
Rock et al., “A family of human receptors structurally related toDrosophilaToll,”Proc. Natl. Acad. Sci. U.S.A. 95:588-93 (1998).
Samakovlis et al., “In vitro induction of cecropin genes—an immune response in aDrosophilablood cell line,”Biochem. Biophys. Res. Commun. 188:1169-75 (1992).
Samatey et al., “Crystallization of the F41 Fragment of Flagellin and Data Collection from Extremely Thin Crystals,”J. Struct. Biol. 132:106-111 (2000).
Samatey et al., “Structure of the bacterial flagellar protofilament and implications for a swi

Affiliated with

Also associated with

Rating

Toll-like receptor 5 ligands and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Toll-like receptor 5 ligands and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Toll-like receptor 5 ligands and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2668049